Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Pinard

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|February 4, 2026
Differences in blood levels of neuroligin-derived peptides in a cohort for early detection of Alzheimer's diseaseMilton Guilherme Forestieri Fernandes, Maxime Pinard, Esen Sokullu, et al.
The Journal of Gene Medicine|January 15, 2008
A ligand-pseudoreceptor system based on de novo designed peptides for the generation of adenoviral vectors with altered tropismYue Zeng, Maxime Pinard, Jaïro Jaime, et al.
The Journal of Biological Chemistry|March 11, 2005
MxA, a member of the dynamin superfamily, interacts with the ankyrin-like repeat domain of TRPCMarc P Lussier, Sylvie Cayouette, Pascale K Lepage, et al.
Biomolecules|July 27, 2024
Towards a Treatment for Leukodystrophy Using Cell-Based Interception and Precision MedicineBenoit Coulombe, Alexandra Chapleau, Julia Macintosh, et al.
Frontiers in Neurology|November 2, 2023
Biallelic pathogenic variants in <i>POLR3D</i> alter tRNA transcription and cause a hypomyelinating leukodystrophy: A case reportJulia Macintosh, Stefanie Perrier, Maxime Pinard, et al.
American Journal of Human Genetics|January 8, 2021
De novo variants in POLR3B cause ataxia, spasticity, and demyelinating neuropathyDjurdja Djordjevic, Maxime Pinard, Marie-Soleil Gauthier, et al.
American Journal of Human Genetics|April 8, 2022
De novo variants in POLR3B cause ataxia, spasticity, and demyelinating neuropathyDjurdja Djordjevic, Maxime Pinard, Marie-Soleil Gauthier, et al.
Molecular Brain|June 22, 2019
The leukodystrophy mutation Polr3b R103H causes homozygote mouse embryonic lethality and impairs RNA polymerase III biogenesisKarine Choquet, Maxime Pinard, Sharon Yang, et al.
Molecular Cancer Therapeutics|February 13, 2015
The IGF-Trap: Novel Inhibitor of Carcinoma Growth and MetastasisNi Wang, Roni F Rayes, Seyyed Mehdy Elahi, et al.
Brain : a Journal of Neurology|August 28, 2023
Hypomyelination, hypodontia and craniofacial abnormalities in a Polr3b mouse model of leukodystrophyMackenzie A Michell-Robinson, Kristin E N Watt, Vladimir Grouza, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|February 4, 2026
Differences in blood levels of neuroligin-derived peptides in a cohort for early detection of Alzheimer's diseaseMilton Guilherme Forestieri Fernandes, Maxime Pinard, Esen Sokullu, et al.
The Journal of Gene Medicine|January 15, 2008
A ligand-pseudoreceptor system based on de novo designed peptides for the generation of adenoviral vectors with altered tropismYue Zeng, Maxime Pinard, Jaïro Jaime, et al.
The Journal of Biological Chemistry|March 11, 2005
MxA, a member of the dynamin superfamily, interacts with the ankyrin-like repeat domain of TRPCMarc P Lussier, Sylvie Cayouette, Pascale K Lepage, et al.
Biomolecules|July 27, 2024
Towards a Treatment for Leukodystrophy Using Cell-Based Interception and Precision MedicineBenoit Coulombe, Alexandra Chapleau, Julia Macintosh, et al.
Frontiers in Neurology|November 2, 2023
Biallelic pathogenic variants in <i>POLR3D</i> alter tRNA transcription and cause a hypomyelinating leukodystrophy: A case reportJulia Macintosh, Stefanie Perrier, Maxime Pinard, et al.
American Journal of Human Genetics|January 8, 2021
De novo variants in POLR3B cause ataxia, spasticity, and demyelinating neuropathyDjurdja Djordjevic, Maxime Pinard, Marie-Soleil Gauthier, et al.
American Journal of Human Genetics|April 8, 2022
De novo variants in POLR3B cause ataxia, spasticity, and demyelinating neuropathyDjurdja Djordjevic, Maxime Pinard, Marie-Soleil Gauthier, et al.
Molecular Brain|June 22, 2019
The leukodystrophy mutation Polr3b R103H causes homozygote mouse embryonic lethality and impairs RNA polymerase III biogenesisKarine Choquet, Maxime Pinard, Sharon Yang, et al.
Molecular Cancer Therapeutics|February 13, 2015
The IGF-Trap: Novel Inhibitor of Carcinoma Growth and MetastasisNi Wang, Roni F Rayes, Seyyed Mehdy Elahi, et al.
Brain : a Journal of Neurology|August 28, 2023
Hypomyelination, hypodontia and craniofacial abnormalities in a Polr3b mouse model of leukodystrophyMackenzie A Michell-Robinson, Kristin E N Watt, Vladimir Grouza, et al.
Pageof 2